ArticleBone marrow transplantation2024
A comparison of long-term outcomes by donor type in the era of post-transplantation cyclophosphamide for aggressive adult T-cell leukemia/lymphoma.
Asao Hirose, Hideo Koh, Mika Nakamae, Yasuhiro Nakashima, Mitsutaka Nishimoto, Hiroshi Okamura, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Kentaro Ido and 3 more
Abstract readComparative StudyLetter
In one paragraphArticle in Bone marrow transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors at 1 institution in 1 country.
Asao HiroseDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Hideo KohDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Mika NakamaeDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-9200-4804 Yasuhiro NakashimaDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0003-3025-723X Mitsutaka NishimotoDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-0388-3836 Hiroshi OkamuraDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Yosuke MakuuchiDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-5230-6904 Masatomo KunoDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0003-4548-147X Teruhito TakakuwaDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Kentaro IdoDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Kazuki SakatokuDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Masayuki HinoDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Hirohisa NakamaeDepartment of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. hirohisa@omu.ac.jp.ORCID 0000-0003-4203-990X Osaka Metropolitan University · JP
Funding
MEXT | Japan Society for the Promotion of Science (JSPS) 23K06746
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
CyclophosphamideLeukemia-Lymphoma, Adult T-CellAdultAgedAllograftsFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedRetrospective StudiesSurvival RateTissue DonorsTreatment OutcomeCyclophosphamide
Identifiers
PMID38355910
OpenAlexW4391812811
What OpenQuestion holds
Textmetadata
Read underepoch 390